THM Biomedical Inc.
This article was originally published in Start Up
THM Biomedical Inc. has been quietly fabricating bioresorbable architectures useful in tissue engineering for years. The company begins with a well-known biocompatible material, an amorphous form of polylactic acid, and it creates open-celled three-dimensional architectures that suit a wide range of applications in tissue repair and reconstruction.
You may also be interested in...
A broadly enabling technology can be almost a problem for a biomaterials start-up. The challenge is finding and exploiting the killer application.
Wound Solutions Ltd. looks to the paradigm of patient self-care in diabetes to address the gaps in chronic wound care, where the feedback provided by blood glucose monitoring encourages changes in behavior. A small device that is placed under a compression bandage helps patients with venous leg ulcers comply with the steps they should be taking to support wound healing, in the process, collecting data that helps clinicians make informed therapy decisions.
The treatment of chronic wounds is challenging, not only because of the underlying biology, but also because of more practical considerations: fragmentation in the care settings, the logistics of delivering products to patients, and the costs of chronic care. Next generation advanced wound care companies are engineering solutions to these problems.